CIK 0001873835 · <br>Emerging growth company
Immix Biopharma, Inc.
Sign in to watch- Ticker
- IMMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454869378
- Phone
- (888) 958-1084
- Business address
- 11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES, CA, 90064
- Former names
- Immix Biopharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-22 | Ng Carey Director | Grant or award | +6,250 | 26,250 | ||
| 2026-05-22 | Ng Carey Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2026-05-22 | Adams Helen C. Director | Grant or award | +6,250 | 181,004 | ||
| 2026-05-22 | Adams Helen C. Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2026-05-22 | Morris Gabriel S CFO, President | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2026-05-22 | Marquet Magda Director | Grant or award | +6,250 | 52,342 | ||
| 2026-05-22 | Marquet Magda Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2026-05-22 | CHANG NANCY T Director | Grant or award | +6,250 | 428,190 | ||
| 2026-05-22 | CHANG NANCY T Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2026-05-22 | Rachman Ilya M CEO and Chairman | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2026-05-22 | Chudnovsky Yekaterina Director | Grant or award | +6,250 | 6,250 | ||
| 2026-05-22 | Chudnovsky Yekaterina Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2026-05-22 | BUCHAN JANE Director | Grant or award | +6,250 | 28,705 | ||
| 2026-05-22 | BUCHAN JANE Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2026-05-22 | Hsu Jason Director | Grant or award | +6,250 | 899,250 | ||
| 2026-05-22 | Hsu Jason Director | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | ||
| 2025-12-10 | Rachman Ilya M CEO and Chairman | Purchase | +746 | $6.67 | $5K | 1,141,683 |
| 2025-12-10 | Morris Gabriel S CFO | Purchase | +770 | $6.58 | $5K | 291,429 |
| 2025-12-08 | Morris Gabriel S CFO | Option exercise | +156,000 | $0.80 | $125K | 426,844 |
| 2025-12-08 | Morris Gabriel S CFO | Option exercise · Warrants (right to purchase) | −96,000 | 0 |
Page 1 of 7 · 124 trades